CIK 0001095981
- Non-accelerated filer
- Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330827593
- Phone
- +1 737-255-7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Financial Officer acquired 67,452 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 201,632 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Executive Officer acquired 159,681 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 38,323 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.51 ($10,200)
- 4 Exercise or conversion Chief Executive Officer acquired 159,681 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Financial Officer acquired 38,323 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Open-market buy Director bought 110,000 shares at $0.49 ($53,779)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 30 · 592 filings